Sign In
Buy LMAT
$91.64
+0.0200 (+0.0218%)
At Close: Jun 03, 2026
LeMaitre Vascular Inc (NASDAQ:LMAT) Shares Sold by Bank of America Corp DE
09:08am, Friday, 24'th Apr 2020
Bank of America Corp DE decreased its holdings in LeMaitre Vascular Inc (NASDAQ:LMAT) by 5.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owne
Earnings Preview: LeMaitre Vascular (LMAT) Q1 Earnings Expected to Decline
04:32pm, Thursday, 23'rd Apr 2020
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: LeMaitre Vascular (LMAT) Q1 Earnings Expected to Decline
04:32pm, Thursday, 23'rd Apr 2020
LeMaitre (LMAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LeMaitre Vascular (LMAT) Set to Announce Quarterly Earnings on Thursday
06:46am, Thursday, 23'rd Apr 2020
LeMaitre Vascular (NASDAQ:LMAT) is scheduled to issue its quarterly earnings data after the market closes on Thursday, April 30th. Analysts expect the company to announce earnings of $0.16 per share f
Reviewing Cantel Medical (NYSE:CMD) and LeMaitre Vascular (NYSE:LMAT)
07:24am, Wednesday, 22'nd Apr 2020
LeMaitre Vascular (NASDAQ:LMAT) and Cantel Medical (NYSE:CMD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of thei
Curbstone Financial Management Corp Sells 700 Shares of LeMaitre Vascular Inc (NASDAQ:LMAT)
09:20am, Tuesday, 21'st Apr 2020
Curbstone Financial Management Corp cut its holdings in shares of LeMaitre Vascular Inc (NASDAQ:LMAT) by 3.3% during the first quarter, according to the company in its most recent disclosure with the
3 Key Strategies Helping Me Go Through The COVID-19 Crisis
01:03am, Tuesday, 21'st Apr 2020
Focus on dividend growth (forget about dividend yield). Forgive temporary dividend suspension (but remain ruthless). Rethink your sector allocation.
Brokerages Anticipate LeMaitre Vascular Inc (NASDAQ:LMAT) Will Announce Quarterly Sales of $31.18 Million
08:28am, Saturday, 18'th Apr 2020
Wall Street brokerages forecast that LeMaitre Vascular Inc (NASDAQ:LMAT) will report sales of $31.18 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made
Catching The Bottom
07:09am, Friday, 17'th Apr 2020
Each bear market is different, and we don't know if we have hit the bottom yet. It is a good time to rebalance now, but one must do it in an orderly fashion. No
LeMaitre Vascular Inc (NASDAQ:LMAT) Expected to Post Earnings of $0.17 Per Share
10:16am, Thursday, 16'th Apr 2020
Equities research analysts expect LeMaitre Vascular Inc (NASDAQ:LMAT) to post $0.17 earnings per share for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Le
LeMaitre Vascular (NASDAQ:LMAT) PT Lowered to $24.00
09:14am, Thursday, 16'th Apr 2020
LeMaitre Vascular (NASDAQ:LMAT) had its price objective lowered by Canaccord Genuity from $33.00 to $24.00 in a research report issued on Tuesday, BenzingaRatingsTable reports. The brokerage presently
Catching The Bottom
05:34pm, Wednesday, 15'th Apr 2020
Each bear market is different, and we don’t know if we have hit the bottom yet. There are signs of a slowdown in volatility and volume right now, but we are not out of the woods yet.
Canaccord Genuity Maintains Hold on LeMaitre Vascular, Lowers Price Target to $24
05:41pm, Tuesday, 14'th Apr 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 13.) * Chembio Diagnostics Inc (NASDAQ: CEMI)
Lemaitre Vascular (LMAT) Receives a Rating Update from a Top Analyst
10:17am, Tuesday, 14'th Apr 2020
In a report released yesterday, Jason Mills from Canaccord Genuity maintained a Hold rating on Lemaitre Vascular (LMAT – Research
